 |
 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about BiCNU.
No reviews have yet been submitted. Be the first to review this drug.
Micromedex Care Notes:
Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax®-L personalized immune therapies for solid tumor cancers, today...
MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX) announced today that it has dosed the first patient in a Phase 2 clinical trial of MOR208 in...
Lund, Sweden – 22 April 2013 - BioInvent International (OMXS:BINV) announced today that the first patient has been treated in a phase II study of the drug...
Looking for answers? Ask a question or go join the BiCNU support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated May 16th, 2013), Cerner Multum™ (updated May 20th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
